Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Cisplatin (liposomal)

EU orphan designation number: EU/3/07/451   
Active ingredient: Cisplatin (liposomal)
Indication: Treatment of pancreatic cancer
Sponsor: Regulon AE
Afxentiou 7, Alimos, 17455, Athens, Hellas

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/06/2007 Centralised Orphan - Designation EMEA/OD/103/06 (2007)2561 of 08/06/2007